中药调控单胺类神经递质治疗卒中后抑郁的研究进展  

Research Progress of TCM Treatment of Post-stroke Depression by Regulating Monoamine Neurotransmitter

作　　者：张君如 商庆新[1] ZHANG Junru;SHANG Qingxin(Shandong University of Traditional Chinese Medicine,Jinan 250014,China)

机构地区：[1]山东中医药大学,山东济南250014

出　　处：《西部中医药》2023年第4期154-157,共4页Western Journal of Traditional Chinese Medicine

基　　金：国家自然科学基金青年基金(81303028);山东省科技发展计划(2014GSF119038);山东省中医药科技发展计划(2017-040,2019-0107,2019-0094)。

摘　　要：从古今医家对卒中后抑郁的认识入手,阐述了中药调控单胺类神经递质来治疗卒中后抑郁的的研究进展。认为中药可通过调控单胺类神经递质5-羟色胺、多巴胺和去甲肾上腺系统来改善卒中后抑郁患者的症状,提高患者的生存质量。为中药治疗卒中后抑郁提供了临床依据。In the paper,we reviewed the research progress of TCM treatment of post-stroke depression(PSD)by regulating monoamine neurotransmitter starting with the ancient and modern doctors'understanding of PSD.Traditional Chinese medicine could improve PSD patients'symptoms and the survival quality by regulating monoamine neurotransmitter 5-HT,dopamine and noradrenal system,providing clinical basis for TCM therapy of PSD.

关 键 词：卒中后抑郁 中药 5-羟色胺 多巴胺 

分 类 号：R255.2[医药卫生—中医内科学]